Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


caLIMS v2

Product Description

Moxie Informatics builds custom LIMS software for the biotech industry designed to fit any size laboratory at an affordable price. From their work developing LIMS for the National Cancer Institute, Moxie is capable of providing generic solutions from many different laboratory settings.

Moxie Informatics is a health informatics company comprised of experts who are skilled and experienced in the business of Life Science research and Health Care. Their team is intimately familiar with the business of the National Cancer Institute and many of its offices and programs. Moxie’s team resources currently interface with NCI Directors, Program Managers and other government or contractor experts who are working within the CBIIT/caBIG enterprise. Their specific focus is in the areas of program management and providing innovative-value added information technology services to the scientific research community.

Developed by Moxie Informatics, the National Cancer Institute's caLIMS v2 project was launched to create a LIMS that is interoperable within established caBIG standards and guidelines and will track a complete laboratory workflow that uses materials from a specimen management service (e.g. caTissue) to generate experimental results for one of the caBIG data management services (e.g. caArray). The caLIMSv2.c3i0 milestone release is an early release version of the planned caLIMS v2.0 beta release. This caLIMSv2.c3i0 contains much of the functionality related to the administration, customer service, inventory, and reports modules, including: set up of laboratories and users, locations and storage, equipment and software; customer requests, services, and accounts; containers, specimens, reagents, and supplies; and queries, searches, and reports. The goal of this release is to allow the interested community full access to the project results so far for their evaluation, feedback, and possible local customization. Information on the release can be found on the National Cancer Institute's caLIMS v2 Project Wiki at http://www.cancer.gov.

Product caLIMS v2
Company Moxie Informatics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Moxie Informatics
155 Gibbs St., Suite 506 Rockville, MD 20855 USA

Tel: +1 866-205-3962

Email: info@moxieinforamtics.com



Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!